In focus: autologous vs nonmyeloablative transplantation for non-Hodgkin lymphoma.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D002985:Clinical Protocols; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008224:Lymphoma, Follicular / Q000628:therapy*; D018579:Patient Selection; D012008:Recurrence; D000069283:Rituximab; D016879:Salvage Therapy; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab